These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2504753)

  • 21. The cost of drugs.
    N Z Med J; 1969 Jan; 69(440):33-4. PubMed ID: 4974999
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.
    Davit BM; Nwakama PE; Buehler GJ; Conner DP; Haidar SH; Patel DT; Yang Y; Yu LX; Woodcock J
    Ann Pharmacother; 2009 Oct; 43(10):1583-97. PubMed ID: 19776300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biopharmaceutic equivalency and the role of the Food & Drug Administration.
    Hodges RM
    Am J Hosp Pharm; 1968 Mar; 25(3):121-7. PubMed ID: 5658859
    [No Abstract]   [Full Text] [Related]  

  • 24. Generic vs. brand name drugs--quality, not cost, is key issue.
    Stetler CJ
    Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133
    [No Abstract]   [Full Text] [Related]  

  • 25. Critical therapeutic categories: a contraindication to generic substitution?
    Colaizzi JL; Lowenthal DT
    Clin Ther; 1986; 8(4):370-9. PubMed ID: 3731208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FDA reiterates warning against online drug buying.
    Rados C
    FDA Consum; 2004; 38(5):17. PubMed ID: 15595143
    [No Abstract]   [Full Text] [Related]  

  • 27. Generic drugs in reproductive medicine: is the value anticipated the value obtained?
    Keith LG; Method MW
    Int J Fertil; 1987; 32(4):268-78. PubMed ID: 2887523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Curbing counterfeit drugs.
    FDA Consum; 2006; 40(5):11. PubMed ID: 17326307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generic Drugs.
    Med Lett Drugs Ther; 2002 Oct; 44(1141):89-90. PubMed ID: 12405134
    [No Abstract]   [Full Text] [Related]  

  • 30. Generic-therapeutic equivalence--enigma or myth?
    Shirkey HC
    Hawaii Med J; 1970; 29(3):201-2. PubMed ID: 5416016
    [No Abstract]   [Full Text] [Related]  

  • 31. The control of drugs and therapeutic freedom.
    Dunlop D
    Proc R Soc Med; 1968 Aug; 61(8):841-6. PubMed ID: 5695368
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. United States Food and Drug Administration's viewpoint.
    Ley HL; Desmond FH
    Can Med Assoc J; 1968 Feb; 98(6):318-21. PubMed ID: 5636100
    [No Abstract]   [Full Text] [Related]  

  • 33. Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.
    Palylyk-Colwell E; Jamali F; Dryden W; Friesen E; Koven S; Mohamed I; Osmond B; Alessi-Severini S; Sheldon L; Sheldon R; Tam Y; Tsuyuki R; Zhanel G
    J Pharm Pharm Sci; 1998; 1(1):2-7. PubMed ID: 10942966
    [No Abstract]   [Full Text] [Related]  

  • 34. When Is a Medicine Good Enough?: Science, Similarity, and the History of Generic Drugs.
    Greene JA
    Clin Pharmacol Ther; 2019 Feb; 105(2):290-291. PubMed ID: 30703267
    [No Abstract]   [Full Text] [Related]  

  • 35. Genesis of generic drugs.
    Calesnick B; Kreider LA; Dinan A
    Pa Med; 1986 Dec; 89(12):32, 34, 36. PubMed ID: 3808720
    [No Abstract]   [Full Text] [Related]  

  • 36. United States Food and Drug Administration requirements for approval of generic drug products.
    Meyer MC
    J Clin Psychiatry; 2001; 62 Suppl 5():4-9; discussion 23-4. PubMed ID: 11305846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What's happening with pharmaceuticals? And how will it impact your practice?
    Williams B
    Tenn Med; 2005 May; 98(5):213-6. PubMed ID: 15934528
    [No Abstract]   [Full Text] [Related]  

  • 38. [Control of drugs in foreign countries].
    Buriánek J; Parrák V
    Cesk Farm; 1973 Jul; 22(6):247-53. PubMed ID: 4732551
    [No Abstract]   [Full Text] [Related]  

  • 39. Generic and alternative brand-name pharmaceutical equivalents: select with caution.
    Hendeles L; Hochhaus G; Kazerounian S
    Am J Hosp Pharm; 1993 Feb; 50(2):323-9. PubMed ID: 8480793
    [No Abstract]   [Full Text] [Related]  

  • 40. Controlling the quality of Uncle Sam's drugs.
    Hecht A
    FDA Consum; 1977 May; 11(4):22-3. PubMed ID: 10316531
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.